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Danio rerioods have been successfully employed in many organisms including zebraﬁsh.
However, accurate spatiotemporal control of transgene expression is still difﬁcult to achieve. Here we
describe a system for chemical-inducible gene expression and demonstrate its feasibility for generating
transgenic driver lines in zebraﬁsh. The key element of this system is a hybrid transcription factor engineered
by fusion of the DNA-binding domain of the bacterial LexA repressor, a truncated ligand-binding domain of
the human progesterone receptor, and the activation domain of the human NF-κB/p65 protein. This hybrid
transcription factor (LexPR transactivator) binds to the synthetic steroid, mifepristone (RU-486), and
functions in a ligand-dependent manner to induce expression of the gene(s) placed under the control of a
synthetic operator-promoter sequence that harbors LexA binding sites. Transgene expression is strictly
controlled and can be induced at any stage of the life cycle through administration of mifepristone in the
water. To demonstrate the utility of this system, we generated stable transgenic lines which allow inducible
tissue-speciﬁc expression of activated K-ras(V12). Combined with the Ac/Ds-mediated transgenesis, the
LexPR expression system has many potential applications in the ﬁelds of genetics and biotechnology.
© 2008 Elsevier Inc. All rights reserved.IntroductionManydevelopmentally regulated genes are re-deployed at different
times of development in different cell types. Therefore, in order to
dissect their unique functions in each context in a precise manner,
methods for manipulation and spatiotemporal control of gene expres-
sion are essential. Using a simple promoter to drive target gene
expression is the most commonly used strategy in transgenic ﬁsh and
other vertebrate species. However, the number of well-characterized
tissue-speciﬁc promoters is very limited. Furthermore, constitutive
and ubiquitous expression is often not adequate or disadvantageous,
for example, when gene expression at earlier stages of development
causes severe effects, which obscure the roles of this gene at later
stages or when expression of the transgene causes infertility or
premature lethality, hindering generation and maintenance of trans-
genic animals.
One way to address these problems is by generating two inde-
pendent transgenic lines, the “effector(target)” line, carrying a trans-l rights reserved.criptionally silent gene of interest, and the driver line, expressing a
transcription activator which can induce expression of the gene of
interest in double transgenic hybrid driver/effector animals (e.g. GAL4/
UAS system (Davison et al., 2007; Scott et al., 2007)). The use of gene-
and enhancer-trap screening can allow the generation of a large
number of driver lines with various expression patterns of a trans-
cription activator (Kotani et al., 2006; Parinov et al., 2004; Scott et al.,
2007). However, it is not feasible to cover all required spatiotemporal
patterns even in large-scale enhancer-trap screens. Therefore,
improved techniques that permit switching gene expression on and
off when required, would allow more experimental ﬂexibility and
better control of expression.
Heat shock promoters have been utilized in ﬁsh to induce ubiquitous
gene expression at speciﬁc time points by exposure to heat (Bajoghli et
al., 2004). For example, heat-inducible expression of the dominant-
negative form of the FGF receptor driven by a zebraﬁsh hsp70was used
to study the roles of Fgf signaling during regeneration (Lee et al., 2005;
Lepilina et al., 2006). However, heat shock promoters allow relatively
low inducibility and lack spatial control of transgene expression. Also,
using lasers to induce cell-speciﬁc gene expression (Halloran et al.,
2000) is technically difﬁcult and applicable only on a small scale.
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expression combined with the spatial control of tissue-speciﬁc
promoters. Furthermore, binary inducible expression systems allow a
combination of inducibilitywith the power of enhancer-trap screening
(Nicholson et al., 2008). Chemical-inducible expression systems have
been previously applied to study gene functions at various stages of
development. For example, “tet-on” inducible system was used to
dissect multiple roles of genes during chicken somitogenesis, which
would not be possible using a conventional promoter because the
phenotypes caused by the early expression of some genes precluded
studying the effects at the later stages (Watanabe et al., 2007).
Mifepristone-inducible expression of FGF-3 during postnatal devel-
opment, and in the adult tissues was used to assess the complex
temporal roles of the FGF signaling in organ development, adult
physiology and tumor development in transgenic mice, because
manipulation of FGF signaling at earlier stages caused abnormal
development and neonatal lethality (Ngan et al., 2002; Zhao et al.,
2001). In another example, inducible expression of dominant-negative
thyroid hormone receptor was used to determine the developmental
periods within which thyroid hormone controls speciﬁc aspects of
Xenopus morphogenesis (Das and Brown, 2004). Inducible expres-
sion used in this example also helped to circumvent the severe
developmental abnormalities and death caused by expression of the
dominant-negative receptor using conventional promoters.
Hormone-responsive transcriptional activators have been used
previously in ligand-inducible strategies to regulate target gene
expression. For example, a chimeric transactivator consisting of a
mutated progesterone receptor ligand-binding domain fused to the
HSV VP16 transactivation domain and the yeast GAL4 DNA-binding
domain (DBD) has been shown to transactivate UAS-controlled target
genes only in the presence of mifepristone/RU-486 (Wang et al., 1994).
A similar chimeric transactivator GLp65, which contains the activation
domain of the human p65 protein (instead of VP16), has been used for
inducible expression of target genes in mammalian cells (Burcin et al.,
1999). Mifepristone-inducible GAL4/UAS-based techniques have been
successfully used in transgenic mice (Kellendonk et al., 1999; Ngan et
al., 2002; Pierson et al., 2000; Wang et al., 1997; Zhao et al., 2001), in
Xenopus (Das and Brown, 2004) and in Drosophila (Nicholson et al.,
2008). Although the GAL4/UAS system has been widely utilized
previously, some reports suggest that high level of GAL4 expression
can be toxic and causes developmental defects (Habets et al., 2003;
Kramer and Staveley, 2003; Scott et al., 2007).
One alternative to GAL4/UAS-based systems is to use the DNA-
binding domain from the bacterial repressor LexA coupled with the
speciﬁc operator DNA fragment/s. Since the structure of LexA DBD does
not resemble those of eukaryotic transcription factors (Oertel-Buchheit
et al., 1992), it is less likely to bind to the cis-elements of endogenous
promoters. It was previously utilized in estradiol-inducible gene
expression systems, developed for use in transgenic plants, since plants
lack endogenous estrogen hormones (Guo et al., 2003; Zuo et al., 2000).
This expression system caused no apparent toxicity in transgenic plants.
Although several chemical-inducible systems have been developed
for use in mammals and mammalian cells, there has been only one
recent publication in zebraﬁsh. In this report, a tebufenozide-inducible
system was tested in transient assay (Esengil et al., 2007). It utilized a
chimeric transcription factor containing GAL4 DNA-binding and
dimerization domains, VP16 activation domain and ecdysone receptor
(EcR) ligand-binding domain. However, this chemical-inducible system
has not been used yet for generation of true transgenic animals or for
generating driver/effector lines, so the efﬁcacy of this system is not clear.
Here, we describe a new system for chemical regulation of gene
expression utilizing the DNA-binding domain of the bacterial LexA
protein, the truncated ligand-binding domain of the human proges-
terone receptor and the activation domain of the human p65 protein.
We have successfully tested this system in germline-transgenic
zebraﬁsh and, and showed that transgene expression can be tightlyregulated by mifepristone. Finally, we demonstrate the feasibility of
this system for generation of cell-speciﬁc driver lines using enhancer
trapping and show driver/effector trans-activation in double trans-
genic hybrids between independent driver and effector lines.
Results
System design
We have engineered a system for chemically regulated transcrip-
tion consisting of two basic elements: a chimeric transcription factor
and a cis-acting operator-promoter sequence containing binding sites
for this transcription factor (Fig. 1). The transcription factor (LexPR
transactivator) is a fusion of the DNA-binding domain of the bacterial
LexA protein (residues 1–87) (Horii et al., 1981; Miki et al., 1981), the
truncated ligand-binding domain of the human progesterone receptor
(residues 640–914) and the activation domain of the human p65
(residues 283–551) (Burcin et al.,1999) (LexDBD-PRLBDΔ-p65AD; Supple-
mentary Data 1). The operator-promoter sequence (LexOP) consists of
a synthetic LexA operator (containing four ColE1 operator sequences
(Ebina et al., 1983)) fused to a minimal 35S promoter from Cauliﬂower
Mosaic Virus (Zuo et al., 2000) (Fig. 1, Supplementary Data 1, 2). The
LexPR transactivator binds to the operator and induces the transcrip-
tion of the gene of interest placed under control of LexOP only upon
binding of the progesterone antagonist, mifepristone (commonly
known as RU-486), to the progesterone receptor LBD. The actual
sequence of events leading to transcription activation is unclear.
Two strategies for using this system are outlined in Fig. 1. The most
versatile scheme involves generation of two separate transgenic lines: a
driver line expressing the LexPR transactivator and an “effector” or
“target” line carrying a gene of interest under the control of the LexOP
(Fig. 1A). Crossing a driver with an effector line generates double
transgenic offspring capable of expressing the gene of interest in
speciﬁc tissues upon stimulation by mifepristone. This strategy allows
combinational experiments: the same driver line can be used to express
various genes in the same cells and conversely, the same effector line
can be crossed to various drivers to express gene of interest in different
cell or tissue types. Furthermore, large number of driver lines with
various expression patterns can be easily generated using enhancer- or
gene-trap strategies (Parinov et al., 2004; Scott et al., 2007). The effector
cassette (LexOP:gene of interest) can also be placed together with the
LexPR transactivator gene into the same vector construct (Fig. 1B). This
allows straightforward generation of F1 transgenic ﬁsh capable of
inducible expression of a gene of interest in just one generation. This
strategy is particularly appropriate whenworking with a single gene of
interest and a suitable promoter. It is also easier to manipulate and
maintain the ﬁsh carrying the transgene in a single locus.
To test the LexPR expression system we ﬁrst generated a qdriver-
reporterq construct pDs(krt8:LPR-LOP:EGFP) containing two compo-
nents: the LexPR transactivator coding sequence under the 0.5-kb
keratin8 promoter and an EGFP reporter gene under the control of the
LexOP sequence (Fig. 1A, Supplementary Data 1). The 0.5-kb keratin8
promoter drives expression in skin epithelia but it frequently generates
various enhancer-trap expression patterns depending on the surround-
ing genomic environment (Parinov et al., 2004). This allows screening
for enhancer-trap driver lines expressing LexPR transactivator in
different cells and tissues. The pDs(krt8:LPR-LOP:EGFP) also contains
the Ds cis-required sequences to facilitate generation of transgenic lines
and random insertion screenings (Emelyanov et al., 2006).
Reporter expression in transgenic driver lines is induced and tightly
controlled by mifepristone
We generated transgenic driver lines that carried LexPR driver-
reporter cassette inserts in the genome and produced various reporter
expression patterns activated in presence of mifepristone (Fig. 2).
Fig. 2. EGFP expression patterns in four independent LexPR driver-reporter lines showing different enhancer-trap events. Expression of EGFP reporter was induced in transgenic F2
embryos by adding mifepristone to the egg water at 1 μM ﬁnal concentration at 24 hour post-fertilization onwards. Images were captured at 96 hour post-fertilization. No EGFP
ﬂuorescence was detected in the control populations of ﬁsh that were not treated with mifepristone (not shown). (A) Strong expression in the cell layer at the bottom of the ear
(possibly sensory patches), at the olfactory bulb region (ob) and in discrete cells of midbrain (head, dorsal view). (B) Strong expression in the diencephalon (d) and cerebellum (c), lens
and in discrete cells of the tectum (t) and hindbrain (hb) (head, dorsal view). (C) Expression in the olfactory bulbs (head, ventral view). (D) Speciﬁc expression in a subset of muscle
cells in the somites (lateral view above yolk extension).
Fig. 1. Schematic representation of the mifepristone-inducible LexA-based gene expression system. The LexPR driver-reporter binary cassette contains two transcription units: the
gene encoding a chimeric LexPR transactivator (LexDBD-PRLBDΔ-p65AD) under the control of an enhancer-trap promoter (PET) and the EGFP reporter gene under the control of a
minimal promoter (miniP35S) fused to a synthetic LexA operator. The effector cassette harbors a gene of interest under the control of the minimal 35S promoter fused to the synthetic
LexA operator. To activate transcription of the gene of interest the LexPR transactivator has to be produced from a separate driver cassette. The LexPR transactivator binds to the LexA
operator sequence to activate the transcription of the downstream genes only in the presence of mifepristone (RU 486). The cassettes are ﬂanked by cis-required sequences of Ds
transposon (black arrowheads) to facilitate generation of transgenic lines. (A) A modular expression system utilizing separate driver and effector cassettes. In double transgenic ﬁsh
carrying both cassettes, expression of the gene of interest is activated in trans by the LexPR transactivator produced from the driver (driver-reporter) construct. (B) One cassette
system. The LexPR transactivator gene and a gene of interest are cloned into the sameDs transposon vector (driver-effector). Although, this binary cassette lacks a reporter gene, it can
be introduced directly into the transgenic ﬁsh homozygous for a separate reporter cassette. It is preferable to use a different transposon system (e.g. Tol2, indicated by white
arrowheads) for the reporter cassette to avoid the unwanted activation by Ac transposase.
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adding mifepristone to the growth water at ﬁnal concentration of
1 μM and 100 nM. Strong EGFP expression could also be induced at
low concentration of 10 nM but it required 24 h of incubation. The
lowest tested concentration of 1 nM induced signiﬁcantly weaker
signal.
Importantly, in the absence of mifepristone, neither EGFP
ﬂuorescence nor EGFP transcript was detected in transgenic embryos
(Supplementary Fig. 1, lane 1; Fig. 3B and data not shown). Therefore,
this expression system allows tight transcriptional control of the
transgene with no detectable background.
Although, krt8 promoter does not turn on until 4.5 hpf (Gong et al.,
2002), we generated transgenic ﬁsh with maternal expression from
this promoter via enhancer trapping (Parinov et al., 2004), and tested
the ability of this system to regulate maternal expression of trans-
genes. Transgenic F2 females harboring the driver-EGFP construct in
their genomes were treated with 1 μM mifepristone for 12 h before
crossing to the wild type males and their offspring was screened for
EGFP ﬂuorescence before midblastula transition. We isolated two
families with females that produced GFP-positive eggs following such
treatment (Supplementary Fig. 2). Therefore, LexPR gene expression
system can be used to regulate maternal expression of transgenes.
We did not observe obvious side effects on zebraﬁsh development
using this system even upon induction with high concentration of
mifepristone (10 μM) at 1-cell stage (data not shown). Although in one
line induction of strong expression during early development occa-
sionally caused developmental delay in some embryos, they later
recovered and did not exhibit morphological abnormalities. We also
treated the WT embryos with 1 μM mifepristone from fertilization
onwards and scored by the overall morphological appearance
(including swim bladder inﬂation state) of 5-dpf larvae. Comparisons
with untreated embryos shows that mifepristone alone causes
absolutely no side effects on the rate of development or morphology.
Only treatment with 100 μM mifepristone (1000-fold higher then
required to achieve robust induction; at this concentration mifepris-
tone precipitates from the normal growth media) caused marginally
slower developmental rate, but the ﬁsh recoveredwithout any evident
morphological defects.
Rate of the transcription induction
To estimate the rate of induction accurately, it is more appropriate
to measure the transcript rather than the protein product, especially if
the gene of interest contains sequences for RNAi, microRNA or other
non-coding RNAs. Hence, we examined the spatiotemporal transcrip-
tion response to mifepristone induction using whole mount in situ
hybridization to detect EGFP transcripts (Figs. 3B–G). For this purpose,
we used a transgenic driver line with an enhancer-trap EGFP
expression pattern shown in Fig. 2A. The F2 embryos from this line
were treated with 1 μM mifepristone from 48 hpf onwards and
aliquots of 20 embryos were collected at various times after induction.
No reporter transcript expression was observed without induction.
The reporter transcript was ﬁrst detected at the bottom of the otic
capsule 1 hour post-induction and its level increased gradually during
ﬁrst 9 h of induction.Fig. 3. Rate of mifepristone-induced activation of transcription. Whole mount RNA in
situ hybridizations with the LexPR- (A) and EGFP-speciﬁc (B–G) antisense RNA probes.
The transgenic driver-reporter line used here normally expresses EGFP in a subset of
tissues shown in Fig. 2A. (A) Expression pattern of the LexPR transactivator RNA at
48 hpf. The strongest expression is found in the cell layer at the bottom of the otic
capsule (possibly sensory patches) and at the olfactory bulb region. The diffused
expression in the dorsal brain appears quite strong on the lateral view due to specimen
thickness; the expression is actually weak as seen on the dorsal view. The 72 hpf LexPR
expression pattern is similar (image not shown). (C–G) EGFP reporter transcript 1 (C), 3
(D), 6 (E), 9 (F) and 24 (G) hours after induction with 1 μM mifepristone (RU486) at
48 hpf stage onwards. No background EGFP transcript was observed without
mifepristone (B).EGFP transcript was observed within a subset of the LexPR
expression pattern (Fig. 3), mostly in the areas of strong LexPR
expression.
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mifepristone withdrawal
To ﬁnd out if removal of mifepristone allows switching off gene
expression, and to determine the time needed for downregulation
after mifepristone withdrawal, we performed the following experi-
ment. Transgenic F2 embryos carrying the driver-reporter construct
were treated at 36 hpf with different concentrations of mifepristone
Supplementary Table 1. After 1 or 12 h of mifepristone treatment, the
embryos were rinsed and transferred intowater withoutmifepristone.
EGFP ﬂuorescence was observed and recorded at different times after
withdrawal of mifepristone. In parallel, we also observed embryos
that were continuously treated with the drug. The results of the
experiment are shown in Supplementary Table 1A and summarized in
Supplementary Table 1B. We observed EGFP ﬂuorescence in the
embryos for 5 days in mifepristone-free water following 12 hour
treatment with 1 μM mifepristone (Supplementary Table 1A). EGFP
transcript was also detected by RT-PCR 5 days after withdrawal ofFig. 4. Driver-effector trans-activation. Two independent driver lines with different LexPR tra
Fig. 2A, (B)— the driver line shown in Fig. 2D. Each driver line was crossed with a transgenic e
gene under control of the LexOP. The hybrid F3 embryos that were double transgenic for the
Bottom panel is a combined image showing both reporters EGFP and mCherry: green indica
levels of mCherry and EGFP ﬂuorescence (notice that these colors do not constitute true mo
there are cells that yield brighter mCherry ﬂuorescence than the EGFP and vice-versa. mCher
upon treatment with mifepristone. No background EGFP/mCherry ﬂuorescence was detec
mifepristone (not shown). Images were captured at 96 hour post-fertilization. (A) Strong ex
olfactory bulb region and in various neurons (head, dorsal view). Notice the autoﬂuorescen
Expression is detected in the speciﬁc subtype of muscle cells (lateral view). Two lines of domifepristone from the water (Supplementary Fig. 1, lane 5). By
lowering the concentration to 10 nM and decreasing the length of
exposure length to 1 h, the switch-off delay can be shortened (Supple-
mentary Table 1), but the maximum expression level produced under
these induction conditions is lower.
Trans-activation of effector expression in double transgenic ﬁsh
harboring driver and effector constructs
To demonstrate the feasibility of using LexPR driver lines to drive
transgene expression in trans (Figs. 1A, B), we generated a LexA-
effector construct pDs(cry:C-LOP:Ch). This effector cassette harbors a
gene for red ﬂuorescent protein qmCherryq under the control of the
LexOP sequence (Supplementary Data 2). It also contains Ds cis-
required sequences to facilitate transposon-mediated integration into
the genome and an extra selection marker, ECFP under the control of
the zebraﬁsh Crystallin beta B promoter, which generated cyan
ﬂuorescence in the lens (Supplementary Fig. 3). The presence of thensactivator expression patterns were studied: (A)— represents the driver line shown in
ffector line (different effector lines were used in panels A and B), which carried mCherry
driver and effector cassettes were treated with 1 μMmifepristone from 24 hpf onwards.
tes excess of EGFP ﬂuorescence, red — excess of mCherry ﬂuorescence, yellow— similar
lar ratios between the reporters). Although, most positive cells express both reporters,
ry ﬂuorescence is not detected in the effector lines containing only the effector cassette
ted in the control populations of double transgenic ﬁsh that were not treated with
pression is in the cell layer at the bottom of the ear (possibly sensory patches), at the
ce from the iridophores in the eye that is visible only through the EGFP ﬁlter set. (B)
ts show autoﬂuorescence from the iridophores.
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transgenic lines. Five stable transgenic lines carrying the LexA-effector
inserts in their genome were generated. No background mCherry
ﬂuorescence was detected in any of the effector lines treated with
1 μM mifepristone. The effector lines were crossed with the driver-
EGFP lines and the transgenic lines carrying both constructs in their
genomes were obtained. No background EGFP and mCherry ﬂuores-
cence was detected in the double transgenic ﬁsh prior to treatment
with mifepristone. Upon treatment of the double transgenic embryos
with 1 μM mifepristone, both reporters EGFP (driver) and mCherry
(effector) were co-expressed in the same tissues and cell types (Fig. 4,
Supplementary Fig. 3). For example, Fig. 4B shows expression of both
reporters only in speciﬁc muscle cells; Supplementary Fig. 3-III shows
both reporters expressed in epithelial skin cells; Supplementary Fig. 3-
I shows expression of both reporters under the control of the gfap:
LexPR driver in the same regions of the CNS.
Thus, the driver lines can be used for trans-activation of the genes
of interests cloned into the effector cassette.
Variability and mosaicism of reporter expression
We observed variegation in the expression levels of both reporters
(Fig. 4; Supplementary Fig. 3). Variegation was evident even among
cells of the same type in the same ﬁsh (mosaicism; Fig. 4B, Supple-
mentary Fig. 3-III). Mosaic activation of reporter expression was more
apparent in double transgenic lines that harbored both driver andFig. 5. Inducible expression of EGFP-KrasV12 in transgenic zebraﬁsh. Transgenic zebraﬁsh l
containing EGFP-KrasV12 under control of the LexOP, F2 (A–E and G). (A) 24 hpf, no induction.
observed in the skin epithelia, the notochord sheath (lateral view, B), in the forebrain (ventra
onwards, lateral view. Notochord, brain and cranial skeleton are severally affected by the E
formed clusters. (E) Transformation of the sheath cells surrounding the notochord. The top a
from 10 hpf onwards. Bottom panel shows notochord of the untreated control. (F) Trans
containing EGFP gene under control of the LexOP. 24 dpf, 1 μM mifepristone treatment sta
epithelial shape and uniformly cover the entire body. (G) 4 dpf. Expression of EGFP-KrasV12 wa
there is much less developmental abnormalities, but the cells of skin epithelia cells acquireeffector constructs allowing comparison of one reporter expression
against another (Fig. 4). Most positive cells expressed both reporters,
but the relative level of expression varied signiﬁcantly: some cells
showed brighter EGFP ﬂuorescence than mCherry while in some
others the mCherry ﬂuorescence was brighter (Fig. 4, bottom panel).
Not only the relative brightness of the different reporters but also
individual expression from each LexOP varied among cells of the same
type (Fig. 4B, top and middle panels). Some double transgenic lines
showed brighter and broader expression of EGFP reporter in com-
parison to mCherry ﬂuorescence (Fig. 4B), whereas in some others
mCherry expression was stronger (Supplementary Fig. 3-IB). That
probably reﬂects different genomic environments around individual
LexOP insertion sites or may be due to different copy numbers of the
effector construct in these lines (see Materials and methods). Three
different effector lines crossed to the same driver line produced
slightly different general levels of reporter (mCherry) expression (data
not shown), but all of them showed similar levels of mosaicism and
variegation between different ﬁsh from the same parents (Supple-
mentary Fig. 3-II).
Although, mosaicism caused some differences in the expression of
EGFP vs. mCherry in the same ﬁsh (Fig. 4), we did not observe the
expression of a single reporter exclusively in any tissue occurring in all
individuals, which inherited the same driver and reporter insertions
from the same parents (Supplementary Fig. 3). Thus, transgenes
controlled by independent LexOPs located at different genomic posi-
tions were indeed co-expressed in the same tissues and cell types.ine harboring insertion of the binary driver construct Ds(krt8:LPR-LOP:EGFP-KrasV12)
(B, C) 24 hpf, 1 μMmifepristone treatment from 10 hpf onwards. GFP ﬂuorescence can be
l view, C), all of these organs are abnormal. (D) 4 dpf, 1 μMmifepristone treatment 10 hpf
GFP-KrasV12 expression. Skin epithelial cells lost epithelial cell shape, became globular,
nd the middle panel shows the notochord of 4 dpf ﬁsh treated with 1 μMmifepristone
genic control line that harbors the driver-reporter construct pDs(krt8:LPR-LOP:EGFP)
rting at 10 hpf, showing EGFP expression in the skin epithelia. The skin cells have ﬂat
s induced with 1 μMmifepristone treatment from 1 dpf onwards. Due to later induction,
d rounded shape and formed clusters instead of a continuous layer.
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single driver-reporter vector
To demonstrate practical application of the LexPR gene expression
system we used it for generating transgenic zebraﬁsh lines carrying
the cell-toxic K-rasV12 oncogene to test if it is possible to manipulate
its expression during development.
We had previously attempted to generate enhancer-trap lines that
express a fusion protein of EGFP and activated K-ras2B(V12) (EGFP-
KrasV12 hereafter) using Ds(krt8:EGFP-KrasV12) transgene (unpub-
lished data). However, expression of EGFP-KrasV12 drastically reduced
germline penetrance and, despite the reported efﬁciency of this pro-
moter for enhancer trapping (Parinov et al., 2004), we obtained very
few lines that expressed EGFP-KrasV12 exclusively in skin epithelia.
The epithelial cells in these lines were severely abnormal, but it did
not affect development or viability.
To overcome the toxicity of the EGFP-KrasV12 transgene, we cloned
it into a driver-reporter cassette (instead of the EGFP, see Supple-
mentary Data 1) and used the resulting construct Ds(krt8:LPR-LOP:
EGFP-KrasV12) to generate transgenic ﬁsh. We used short pulse of
exposure to mifepristone (100 nM mifepristone for 1 h) at the 24-hpf
stage to screen F1 embryos. This was done to ensure survival of
transgenic ﬁsh.
The ﬁrst result was restoration of germline penetrance of the
transgene: we have obtained 7 out of 8 screened founders (88% trans-
genesis rate), which produced transgenic progeny with different GFP
ﬂuorescence patterns when induced with mifepristone. This trans-
genesis rate is similar to the transgenesis rate of the Ds(krt8:EGFP)
transgene (Emelyanov et al., 2006), suggesting that Ds(krt8:LPR-LOP:
EGFP-KrasV12) cassette did not affect germline penetrance. In one of
these lines, expression of the transgene could be induced in the
developing forebrain, notochord sheath cells, as well as in the epithelial
skin cells attributed to the basic krt8 promoter activity (Fig. 5). To
induce EGFP-KrasV12 expression in this line, we treated F2 embryos
with 1 μM mifepristone at 10 hpf onwards. This caused speciﬁc effect
on the shape of cells that express EGFP-KrasV12: cells of the skin
epithelia and notochord sheath enlarged, became rounded and formed
clusters of cells instead of forming a continuous layer. The affected skin
epithelial cells lost contacts with the embryo and eventually shed to
the outside environment. Embryos had shortened axis, abnormal brain,
cranial structures, branchial arches and muscles (Fig. 5). Thus, embryo
development was severely affected by expression of KrasV12.
This model demonstrates the ease and feasibility of generating and
manipulating transgenic animals that harbor toxic transgenes. This
strategy should be useful to study effects of not only Ras activity, but
also other oncogenes/factors in the development of various organs
and tissues in zebraﬁsh and in cancer research.
Discussion
Non-inducible gene expression systems utilizing the LexA DNA-
binding domain have been previously used only in invertebrates and
in mammalian cell cultures (Hoshino et al., 2004; Lai and Lee, 2006;
Nettelbeck et al., 1998; Szuts and Bienz, 2000). Here, we have demons-
trated that a LexA-based transcription activation system can be used
for inducible gene expression in vivo in true transgenic vertebrates
and for generating transgenic driver lines.
The LexA-based mifepristone-inducible system provides stringent
control of gene expression with no detectable basal expression of the
reporter gene in the absence of mifepristone. The induction of trans-
cription is relatively fast: the transcript becomes detectable by whole
mount in situ hybridization after only 1 h of induction with 1 μM
mifepristone reaching maximum levels after approximately 9 h of
induction.
Transgene expression can be induced at any developmental stages
and throughout the adult life. Moreover, we were able to induceexpression of maternal products in the egg by exposing females to
mifepristone before fertilization. This is essential when studying the
effects of a transgene on early development before activation of the
zygotic genome at midblastula transition (Pelegri, 2003). It would also
allow the control of expression in germ cells of true transgenic ﬁsh
even when the transgene expression in these cells is detrimental.
The expression can also be switched off, but at a much slower rate
as compared to induction. Even at 5 days after mifepristone with-
drawal (following 12 hour induction with 1 μM mifepristone) the
reporter transcript can be detected by RT-PCR. It is possible that
mifepristone is stable and remains in the tissues long after washout or
it may accumulate in the yolk due to its hydrophobicity. Other factors
include stability of the LexPR and GFP transcripts/proteins. Lower
concentrations of mifepristone and shorter induction time are more
appropriate for switch-off experiments. Published data from mouse
and Drosophila show that both the RU486- and the tetracycline-
inducible systems require long time to turn off (Chikama et al., 2005;
Roman et al., 2001). Thus, our system although very effective in
switching on transgene expression, may need to be optimized further
for switch-off experiments. Supplementary Table 1B provides a rough
guide for optimization of the concentration and induction time.
Transcription from the LexOP is activated only in a subset of cells
expressing the LexPR transcription factor (Fig. 3), mostly in the cells
with relatively high concentration of the LexPR. However, some cells
that expressed low levels of LexPR transactivator produced high levels
of EGFP transcript, suggesting that activation is not simply dose
dependent and may be subject to regulation by other factors. It was
previously reported that transactivator concentration could be an
important parameter in the activation of target genes for TetR-VP16/
tetO inducible binary system (Boger and Gruss, 1999). Stronger pro-
moters and enhancer-trap events or the use of multiple insertion
driver lines may produce broader expression of a target gene. Other
possibilities that may explain this include cell-speciﬁc factors involved
in p65AD transcriptional activation, or cell-speciﬁc drug impermeabi-
lity. This must be taken into account when making an inducible driver
line using a well-deﬁned promoter or a transgenic line with uniform
ubiquitous expression. Depending on the task, speciﬁc expression of
the target gene in the smaller domain compared to the larger ex-
pression domain of the transactivator can be an advantage, since itmay
allow activating expression in speciﬁc cells vs. a whole organ.
In the cells where EGFP expression was induced, there was much
more EGFP than LexPR transcript, that shows that the LexPR/LexOP
system efﬁciently ampliﬁes the expression of the target genes.
Transgenic LexPR lines produce consistent expression from the
LexOP: different animals belonging to the same line express reporters
in the same tissues and cells (Supplementary Fig. 3). Furthermore, two
LexOPs located at different positions in the genome of the same
animal (double transgenic for the driver and effector) also express
reporters in the same cell/tissue types (Fig. 4, Supplementary Fig. 3).
Nevertheless, we observed variegation of reporter expression among
the embryos from the same parents (Supplementary Fig. 3), and
mosaic activation of the reporters among the cells of the same type,
which appeared visually similar to position-effect variegation (Fig. 4B,
Supplementary Fig. 3). Independent effector lines produced similar
degrees of variegation and mosaicism, suggesting that position-effect
variegation does not play a major role in these phenomena. This is
further supported by our observations that position-effect variegation
was rarely found in the conventional enhancer-trap lines carrying
EGFP gene directly controlled by the krt8 promoter (Choo et al., 2006;
Parinov et al., 2004), but most of the LexPR driver lines showed certain
degrees of mosaicism. Published reports suggest that epigenetic
silencing through DNA methylation and chromatin acetylation play
important roles in activator-dependent transgene expression.(Boger
and Gruss, 1999; Kues et al., 2006). The mosaic induction of gene
expression may also reﬂect a stochastic mechanism of transactivator-
dependent transcription activation (Boger and Gruss, 1999; Walters et
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common problem of binary inducible systems and it has been ob-
served with the tetracycline dependent activation systems in trans-
genic mice (Boger and Gruss, 1999; Furth et al., 1994; Gimenez et al.,
2004; Kues et al., 2006; Yamamoto et al., 2001). Furthermore, similar
variegation of reporter expression levels has been noticed in the non-
inducible GAL4-VP16/UAS transgenic zebraﬁsh lines (Davison et al.,
2007; Scott et al., 2007) (data not shown), mifepristone-inducible
GAL4-p65/UAS transgenic zebraﬁsh lines (data not shown) and in the
non-inducible GAL4/UAS Drosophila lines (Goentoro et al., 2006).
Therefore, this problem may be inherent to all binary gene expression
systems. Because of the mosaicism, concentration of the reporter
gene expressed from one LexOP cannot be used as a quantitative
indicator of the target gene expression from another LexOP. Thus,
visualization of the transgene expression using independent live re-
porters, although very useful, must be interpreted with caution.
Expression of the gene of interest in speciﬁc cells can be conﬁrmed
post-experimentally by in situ hybridization.
We have previously tested the non-inducible (Koster and Fraser,
2001) and the chemical-inducible (Burcin et al., 1999) gene expression
systems that utilized the DNA-binding domain of the yeast GAL4
protein in germline-transgenic zebraﬁsh (Supplementary Fig. 4 and
data not shown). These systems could drive expression (constitutive
and inducible respectively) of the UAS-regulated transgenes, but
caused non-speciﬁc developmental defects at a high frequency when
expressed at early developmental stages (Supplementary Fig. 4). The
mifepristone-inducible GAL4-system (Burcin et al., 1999) often
produced irregular expression and the lines with background expres-
sion even without induction (data not shown). Contrary to the GAL4-
based systems, the LexA-based system described here did not cause
obvious adverse effects on zebraﬁsh development even when
mifepristone was added at early developmental stages, it generated
more uniform expression and none of the LexPR driver and effector
lines showed background expression. This may be not entirely
attributable to the different properties of the GAL4 and LexA DNA-
binding domains and their basic recognition DNA sequences, but to
the design of GAL4-based transactivators, number of UAS elements,
promoters and to other important regulatory elements of the system.
Nevertheless, several zebraﬁsh laboratories began generating GAL4-
based driver lines (Davison et al., 2007; Scott et al., 2007). Since LexA-
and GAL4-based systems do not cross-react, it would be possible to
use them together in the same animal and to control them
independently, allowing more sophisticated experimental setups.
The concentration of mifepristone required for effective transcrip-
tion induction (0.01–1 μM in the growth water) is signiﬁcantly lower
(20 to 2000-fold lower) than the antiprogestin dosage used to induce
abortion (10 mg/kg, ~20 μM). This offers safety for the researchers and
the environment. Since the deletion mutant of the human progester-
one receptor LBD does not bind to progesterone, this may also be
potentially useful for human gene therapy (Wang et al., 1994).
Although mifepristone is cheap and safe, in some cases prolonged
exposure to the drug may be undesirable. Furthermore, due to strong
transcript ampliﬁcation, it might be difﬁcult to control the level of the
target gene expression by titration of mifepristone concentration.
Combination of the inducible systemwith Cre/lox recombination sys-
tem can provide a platform for improvements (Zuo et al., 2001).
Indeed, inducible expression of Cre recombinase alone would be a
signiﬁcant improvement of the Cre/lox recombination system (Kel-
lendonk et al., 1999).
Our system features all elements that are necessary for direct
generation of transgenic lines carrying any gene of interest or for
performing large-scale driver-line screenings, and subsequent appli-
cation of these lines to drive controllable expression of genes of
interest. The driver and the effector DNA cassettes are equipped with
the Ds cis-required sequences to facilitate transgenesis. The constructs
contain convenient restriction enzyme recognition sites that allowsingle-step replacement of the EGFP and mCherry coding sequences
with a sequence of interest (Supplementary Data 1, 2). The 0.5-kb krt8
promoter driving the transactivator expression can be used for
enhancer trapping (Parinov et al., 2004), or can also be easily replaced
with different promoters (Supplementary Data 1).
Most elements of these constructs have been previously tested and
used in very distant hosts: bacterial LexA DNA-binding domain and
operator were utilized in plants, invertebrates and in vertebrate cell
cultures (Nettelbeck et al., 1998; Szuts and Bienz, 2000; Zuo et al.,
2000); the hormone binding domain of human progesterone receptor
(hPR-LBD) was explored in yeast (Vegeto et al., 1992); NF-κB/p65
activation domainwas shown to activate transcription in yeast (Moore
et al., 1993); maize Ac/Ds transposable elements performed well in
plants, fungal and animal kingdoms (Emelyanov et al., 2006); 35S
CaMV plant virus minimal promoter and Agrobacterium Nos termi-
nator were used in plants (Zuo et al., 2000); EGFP, mCherry and ECFP
perform well in all tested organisms and the zebraﬁsh krt8 promoter
is active in human and mouse cell cultures (Parinov and Emelyanov,
unpublished data). Thus, this system and our constructs have the
potential to be used in a wide range of hosts from amphibians to
mammals, and possibly in invertebrates, fungi and plants.
Materials and methods
Zebraﬁsh were maintained according to established protocols (Westerﬁeld, 1995).
Generating transgenic ﬁsh using Ac/Ds transposon system
Transgenic ﬁsh carrying insertions of the driver and effector constructs containing
Ds cis-required sequences (Supplementary Data 1, 2) were generated as previously
described (Emelyanov et al., 2006). 5–10 pg of plasmid DNA was co-injected into
zebraﬁsh embryos (yolk center) with 25–50 pg of in vitro synthesized transposase
mRNA at the 1–2-cell stage. The injected ﬁsh were raised and out-crossed to the wild
type, and the resulting embryos were screened for the mifepristone-induced EGFP
expression (driver-reporter lines) or for stable ECFP expression in the lens (effector
lines). For screening of the driver lines, mifepristone was added to the growth water at
1 μM ﬁnal concentration at 24 hpf, and GFP expressing F1 embryos were selected and
raised. We selected only the lines that segregated as a single locus (produced 1:1 ratio
when out-crossed to non-transgenic ﬁsh). Similarly, we selected the effector lines,
which showed 1:1 segregation of cry:ECFPmarker (cyan expression in the lens). We did
not ascertain copy number but only used the lines that segregated as a single locus.
These lines may contain several closely linked copies of the constructs; however, it does
not complicate line maintenance or expression analysis.
RT-PCR
RNA was isolated with RNAEasy Kit (Quiagen). cDNA was synthesized from 0.5 μg
DNA free RNA with 0.5 μg/μl random hexanucleotide and 20 u SuperScript™ Reverse
Transcriptase (Invitrogen) in 20 μl. cDNA mix was inactivated at 70 °C for 15 min and
diluted 5 times with water. 2 μl of the mix was used for PCR with speciﬁc primers: for
LoxPR transactivator aaatcattgccaggttttcg and agcccttccaaaggaattgt; for EGFP reporter
acgtaaacggccacaagttc and gtcctccttgaagtcgatgc. PCR was performed with Taq polymer-
ase (Quiagen) in 20 μl. The PCR cycling conditions: 35 cycles (94 °C for 30 s; 55 °C for
10 s; 72 °C for 10 s).
RNA in situ hybridization
Whole mount in situ hybridization using antisense RNA probes for full length LexPR
transactivator and EGFP labeled with digoxigenin (Roche, USA) was carried out as
previously described (Oxtoby and Jowett, 1993). After in situ hybridization stained
embryos were mounted in PBS-glycerol and viewed using Nikon SMZ1600 stereo-
microscope. Images were taken with Nikon DXM1200F digital camera with the Nikon
ACT-1 software and processed using Adobe Photoshop 7.0.1 software.Acknowledgments
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